Mark B. Schultz
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 10
- Endocrinology top 0.5%
- Vibrio bacteria research studies 3
- Infectious Diseases top 1%
- Antimicrobial Resistance in Staphylococcus 6
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing 7
- Ecology top 2%
- Crustacean biology and ecology 12
-
- Genomics and Phylogenetic Studies 12
- Bacterial biofilms and quorum sensing 4
-
- Marine and fisheries research 4
- Co-authors
- Kathryn E. HoltJustin ZobelRyan R. WickTakehiro TomitaBernard J. PopeMichael InouyeHarriet DashnowChristopher M. Austin
- Journals
- Molecular Phylogenetics and Evolution (4 papers)Genome Medicine (3 papers)Molecular Ecology (2 papers)
- Partner nations
- AustraliaUnited StatesMalaysia
In The Last Decade
Mark B. Schultz
42 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Molecular Medicine 867
- Endocrinology 551
- Infectious Diseases 1.1k
- Clinical Biochemistry 347
- Ecology 1.1k
Countries citing papers authored by Mark B. Schultz
This map shows the geographic impact of Mark B. Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark B. Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark B. Schultz more than expected).
Fields of papers citing papers by Mark B. Schultz
This network shows the impact of papers produced by Mark B. Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark B. Schultz. The network helps show where Mark B. Schultz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark B. Schultz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 76 | |
| 2 | 2022 | 5 | |
| 3 | GISAID’s Role in Pandemic Responsebreakdown → | 2021 | 562 |
| 4 | 2019 | 57 | |
| 5 | 2018 | 51 | |
| 6 | 2018 | 31 | |
| 7 | 2018 | 44 | |
| 8 | 2018 | 21 | |
| 9 | 2017 | 10 | |
| 10 | 2017 | 17 | |
| 11 | 2016 | 147 | |
| 12 | Bandage: interactive visualization of de novo genome assembliesbreakdown → | 2015 | 1718 |
| 13 | 2015 | 61 | |
| 14 | 2014 | 6 | |
| 15 | 2014 | 55 | |
| 16 | 2014 | 86 | |
| 17 | 2014 | 39 | |
| 18 | 2012 | 57 | |
| 19 | 2008 | 34 | |
| 20 | 2008 | 22 |
About Mark B. Schultz
Mark B. Schultz is a scholar working on Molecular Medicine, Clinical Biochemistry, Endocrinology, Ecology and Infectious Diseases, having authored 42 papers that have together received 4.7k indexed citations. Recurring topics across this work include Genomics and Phylogenetic Studies (12 papers), Crustacean biology and ecology (12 papers), Antibiotic Resistance in Bacteria (10 papers), Bacterial Identification and Susceptibility Testing (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Bacterial biofilms and quorum sensing (4 papers), Marine and fisheries research (4 papers) and Vibrio bacteria research studies (3 papers). The work is most often cited by research in Molecular Medicine (867 citations), Endocrinology (551 citations), Infectious Diseases (1.1k citations), Clinical Biochemistry (347 citations) and Ecology (1.1k citations). Mark B. Schultz has collaborated with scholars based in Australia, United States and Malaysia. Frequent co-authors include Kathryn E. Holt, Justin Zobel, Ryan R. Wick, Takehiro Tomita, Bernard J. Pope, Michael Inouye, Harriet Dashnow, Christopher M. Austin, Han Ming Gan and Benjamin P. Howden. Their work appears in journals such as Molecular Phylogenetics and Evolution, Genome Medicine, Molecular Ecology, Invertebrate Systematics and Microbial Genomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.